Alvaro Fernando Lladser Caldera
Professor, Principal Investigator
FUNDACIÓN CIENCIA PARA LA VIDA
Santiago, Chile
Study of antitumor immunity, in particular CD8+ T cells, and harnessing this knowledge to design strategies promoting tumor elimination.
-
Biochemist, UNIVERSIDAD DE CHILE. Chile, 2001
-
Biochemistry, UNIVERSIDAD DE CHILE. Chile, 1999
-
Inmunología, UNIVERSIDAD DE CHILE. Chile, 2007
-
Principal Investigator, Laboratory of Immunoncology Full Time
FUNDACION CIENCIA PARA LA VIDA
Santiago, Chile
2010 - At present
-
Postdoctoral Investigator Full Time
KAROLINSKA INSTITUTE
Cancer Center Karolinska
Stockholm, Suecia
2007 - 2010
-
Undergraduate student Full Time
Gene Pharmacotherapy Lab, Faculty of Chemical and Pharmaceutical, Universidad de Chile
Chile
2000 - 2001
-
Research Assistant Full Time
Gene Pharmacotherapy Lab, Faculty of Chemical and Pharmaceutical Sciences , Universidad de Chile
Chile
2002 - 2002
-
Graduate student Full Time
Cell comunication Lab, Faculty of Medicine, Universidad de Chile
Chile
2004 - 2007
-
Postdoctoral investigator Full Time
Cancer Center Karolinska (CCK), Karolinska Institutet
Suecia
2007 - 2010
-
Principal Investigator Full Time
Fundación Ciencia para la Vida
Chile
2010 - At present
RESEARCH GRANTS
2025-2021 Principal Investigator FONDECYT Regular Grant 1212070.
2021-2010 Principal Investigator Basal Funding Program AFB 170004 to Fundación Ciencia & Vida
2022-2018 Co-Investigator FONDECYT Regular Grant 1180385. PI: Dr. Daniela Sauma.
2021-2017 Principal Investigator FONDECYT Regular Grant 1171703.
2018-2017 Principal Investigator FONDEF IDeA ID16I10369.
2017-2013 Co-Investigator FONDECYT Regular Grant 1130271. PI: Dr. Rodrigo Pacheco.
2016-2012 Principal Investigator CORFO-Innova L2 I+D Aplicada 12IDL2-13348.
2016-2012 Sponsor Investigator FONDECYT Postdoctoral Grant 3130764.
2016-2012 Co-Investigator CORFO-Innova L2 I+D Aplicada 12IDL2-16030. PI: Dr. Rodrigo Pacheco
2014-2011 Principal Investigator FONDECYT Starting Grant 11110525.
2014-2011 Principal Investigator CONICYT Insertion in the Academy Grant 791100038.
PEER REVIEW PANELS
2020-2019 Director Study Group FONDECYT “Biology 2”
2018-2017 Member Study Group FONDECYT “Biology 2”
2014-2013 Reviewer committee FONDEF grants
Since 2020 Reviewer for Nature Communications
Since 2020 Reviewer for Journal for ImmunoTherapy of Cancer
2015-2021 Associate Editor for Human Vaccines & Immunotherapeutics
MEMBERSHIPS
Since 2019 Vice-President ASOCHIN – Asociación Chilena de Inmunología.
Since 2018 Member EATI – European Academy of Tumor Immunology
Since 2017 Member ASOCHIN – Asociación Chilena de Inmunología.
Since 2017 Member SBCCH – Sociedad de Biología Celular de Chile
POSTDOCTORAL SUPERVISION
Since 2021 Dr. Farides Saavedra
2016-2012 Dr. Paola Murgas. Postdoctoral FONDECYT Grant 3130764.
2012-2011 Dr. Andrés Herrada.
THESIS SUPERVISION
Finished PhD Theses
2019 Evelyn Menares. PhD in Biotechnology, Universidad Andrés Bello.
2018 Felipe Gálvez. PhD in Biotechnology, Universidad Andrés Bello.
2016 Nicole Rojas. PhD in Biotechnology, Universidad Andrés Bello.
2015 César Oyarce. PhD in Biomedical Sciences, Universidad de Chile.
2015 Maarten Ligtenberg. PhD in Medical Sciences, Karolinska Institute. Sweden.
Ongoing PhD Theses
Since 2018 Sofia Hidalgo. PhD in Biotechnology, Universidad Andrés Bello.
Since 2019 Diego Figueroa. PhD in Biotechnology, Universidad Andrés Bello.
Finished Magister Theses
2020 Nicolás Méndez. Magister in Biotechnology, Universidad Andrés Bello.
2019 Pablo Cáceres. Magister in Biochemistry, Universidad de Chile.
2018 Ornella Chovar. Magister in Biological Sciences, Universidad de Chile.
2016 Ernesto López. Magister in Biological Sciences, Universidad de Chile.
2017 Luis Mourgues. Magister in Biotechnology, Universidad Andrés Bello.
2017 Sebastián Cruz. Magister in Biochemistry, Universidad de Chile.
2016 Eduardo Durán. Magister in Biochemistry, Universidad de Concepción.
2014 Nicolás Bustamante. Magister in Biological Sciences, Universidad de Chile.
Ongoing Magister Thesis
Since 2020 Francisca Hofmann. Magister in Biotechnology, Universidad Andrés Bello.
Finished Undergraduate Theses
2019 Juan Saavedra. Engineering in Molecular Biotechnology, Universidad de Chile.
2019 Javiera Gómez. Biochemistry, Universidad de Santiago de Chile.
2016 Ernesto López. Engineering in Molecular Biotechnology, Universidad de Chile.
2016 Camila Flores. Engineering in Molecular Biotechnology, Universidad de Chile.
2016 Nicole Araya. Biotechnology, Universidad Mayor.
2016 Felipe Gálvez. Pharmaceutical Chemistry, Universidad de Chile.
2014 Sebastián Cruz. Biology, Pontificia Universidad Católica de Valparaíso.
2012 Jonathan Roco. Biochemistry, Pontificia Universidad Católica de Chile.
2012 Paula González. Biotechnology, Universidad de la Frontera.
Ongoing Undergraduate Theses
2020 Brian Sirguiado. Engineering in Biotechnology, Universidad Andrés Bello.
2020 Pablo Contreras. Engineering in Biotechnology, Universidad Andrés Bello.
Participation in Opinion Leader Workshop, 2012 - 2015. Moderator Biotechnology Session at Encounters Chile Global, Santiago. 2014 “Biomedicina, una carrera contra el tiempo: desde la idea al paciente” ("Biomedicine, a race against time: from idea to patient")
OUTREACH & MEDIA
2020 Interview in television channel Mega Plus, program Mundo Plus, (February 2020)
Url: https://www.lun.com/Pages/NewsDetail.aspx?dt=2019-10-01&NewsID=437320&BodyID=0&PaginaId=8
2020 Interview in online radio program TXS Health in TxS Radio (February 2020)
Url: https://youtu.be/sejFpoxkKLU
2019 Article in national newspaper LUN (1 October 2019)
Url: https://www.lun.com/Pages/NewsDetail.aspx?dt=2019-10-01&NewsID=437320&BodyID=0&PaginaId=8
2018 Program in national television channel 24 Horas (28 November 2018)
Url: https://www.24horas.cl/programas/exploradores/exploradores---miercoles-28-de-noviembre-2897898
2018 Report in national television newscast at Chilevision about the 2018 Nobel Prize (1 October 2018)
Url: https://www.futuro360.com/data/padres-de-la-inmunoterapia-contra-el-cancer-son-ganadores-del-premio-nobel-de-medicina_20181001/
2018 Interview in Radio Pauta, program “La Invención del Futuro” (1 October 2018)
Url: http://www.pauta.cl/programas/la-invencion-del-futuro/alvaro-lladser-sobre-el-descubrimiento-clave-del-cancer
2018 Article in online newspaper El Mostrador (8 October 2018)
Url: http://www.elmostrador.cl/cultura/2018/10/08/la-investigacion-chilena-contra-el-cancer-para-fortalecer-el-sistema-inmunologico/
2018 Article in national newspaper LUN (31 March 2018)
Url: http://www.lun.com/Pages/NewsDetail.aspx?dt=2018-03-31&NewsID=397338&BodyID=0&PaginaId=2
-
Alvaro Lladser
Progress In Vaccination Against Cancer PIVAC-10
Reino Unido, 2010
Best poster, “DAI (ZBP1/DLM-1) as a genetic adjuvant for DNA vaccines that promotes antitumor CTL immunity”
-
Alvaro Lladser
DNA Vaccines 2011: Building on Clinical Progress and Exploring New Targets
Estados Unidos, 2011
Outstanding summary, “Harnessing DNA-sensing pathways of innate immunity for DNA vaccines against cancer”
-
Alvaro Lladser
Cell Biology society of Chile
Chile, 2013
Best Undergratuate poster (Felipe Gálvez Cancino). "NFkB activation during intradermal DNA vaccination controls migration of skin-derived dendritic cells and induction of tumor-protective CTL responses".
-
Alvaro Lladser
Annual Meeting of the Association for Cancer Immunotherapy (CIMT): "Next waves in cancer immunotherapy"
Alemania, 2014
Awarded Best Poster category "Improving Immunity" (Nicole Rojas Colonelli). "DNA vaccination in combination with an RNAi-based genetic adjuvant silencing STAT3 promotes migration of mature dermal dendritic cells and antitumor T cell responses against B16 melanoma".
-
Alvaro Lladser
Cell Biology Society of Chile
Chile, 2015
Best Postraduate poster (Ernesto López)
-
Alvaro Lladser
Chilean Immunology Association
Chile, 2017
Best doctoral poster (Felipe Gálvez)
Caveolin-1 inhibits transcription by hypoxia inducible factor-1α in tumor cells |
Harnessing DNA-sensing pathways of innate immunity for DNA vaccines against cancer |
Ingeniería genética de linfocitos T con receptores quiméricos para el desarrollo de inmunoterapias contra el cáncer |
UNVEILING THE ROLE OF RESIDENT MEMORY CD8 T CELLS IN ANTITUMOR IMMUNITY |
UNVEILING THE ROLE OF RESIDENT MEMORY CD8 T CELLS IN ANTITUMOR IMMUNITY |
INGENIERÍA GENÉTICA DE LINFOCITOS T CON RECEPTORES QUIMÉRICOS PARA EL DESARROLLO DE INMUNOTERAPIAS CONTRA EL CÁNCER |
ROLE OF DOPAMINE RECEPTORS EXPRESSED ON CD4 T-CELLS AND ON DENDRITIC CELLS IN THE DEVELOPMENT OF AUTOIMMUNE RESPONSE AND IN CELLULAR MECHANISMS INVOLVED IN THE PHYSIOPATHOLOGY OF MULTIPLE SCLEROSIS |
Role of dopamine receptors expressed on CD4+ T-cells and on dendritic cells in the development of autoimmune response and in cellular mechanisms involved in the physiopathology of Multiple Sclerosis |
DESARROLLO DE UNA INMUNOTERAPIA CONTRA CANCERES DEL APARATO DIGESTIVO BASADA EN BACTERIOFAGOS ESPECIFICOS PARA EL ANTIGENO CEA |
DESARROLLO DE UNA INMUNOTERAPIA CONTRA CÁNCERES DEL APARATO DIGESTIVO BASADA EN BACTERIÓFAGOS ESPECÍFICOS PARA EL ANTÍGENO CEA |
Desarrollo de una inmunoterapia para cánceres del aparato digestivo basada en bacteriófagos específicos para el antígeno CEA |
Utilización de vectores lentivirales para el desarrollo de una terapia génica para la artritis |
DEVELOPMENT OF RNAI-BASED GENETIC ADJUVANTS MODULATING MASTER REGULATORS OF IMMUNITY AND TOLERANCE TO ENHANCE THE POTENCY OF GENE VACCINES AGAINST CANCER |
Development of RNAi-based genetic adjuvants modulating master regulators of immunity and tolerance to enhance the potency of gene vaccines against cancer |
Fortalecimiento de la investigación, el entrenamiento de capital humano avanzado y el emprendimiento en la Fundación Ciencia para la Vida |
FUNDACIÓN CIENCIA PARA LA VIDA |
Fundación Ciencia y Vida |